Serum Glycoproteomic Alterations in Patients with Diabetic Retinopathy.

ABSTRACT: The precise molecular mechanisms of diabetic retinopathy (DR) pathogenesis are unclear, and treatment options are limited. There is an urgent need to discover and develop novel therapeutic targets for the treatment of this disease. Glycosylation is a post-translational modification that plays a critical role in determining protein structure, function, and stability. Recent studies have found that serum glycoproteomic changes are associated with the presence or progression of several inflammatory diseases. However, very little is known about the glycoproteomic changes associated with DR. In this study, glycoproteomic profiling of the serum of diabetic patients with and without DR was performed. A total of 15 glycopeptides from 11 glycoproteins were found to be significantly altered (5 upreg

SUBMITTER: Sharma A 

PROVIDER: S-EPMC7565786 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature